In the leukemia cell line HL-60 with the NRASQ61L mutation and the pancreatic cancer cell line MIA PaCa-2 with the KRASG12C mutation, the mRNA expression of DOHH, HIST1H2AC, and TAF6 were measured with MEK-I treatments. This evidence concerns the gene DOHH and familial pancreatic carcinoma.